{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Alexandre Rosa Campos"}, {"accession": "MS:1000589", "name": "contact email", "value": "arosacampos@sbpdiscovery.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "SBP Medical Discovery Institute"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Frank Furnari"}, {"accession": "MS:1000589", "name": "contact email", "value": "ffurnari@ucsd.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of California San Diego"}]}], "description": "We found that GSCs were highly sensitive to proteasome inhibition due to an underlying dependency on an increased protein synthesis rate, and loss of autophagy, associated with PTEN loss and activation of the PI3K/mTOR pathway. In contrast, combinatory inhibition of autophagy and the proteasome, resulted in enhanced cytotoxicity specifically in GSCs that did express PTEN. Finally, proteasome inhibition specifically increased cell death markers in 3D glioblastoma organoids, suppressed tumor growth, and increased survival of mice orthotopically engrafted with GSCs. As perturbations of the PTEN/ PI3K axis occur in nearly 50% of GBMs, these findings suggest that a significant fraction of these tumors could be vulnerable to proteasome inhibition.", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=edbf72221abc4e6097db9d9ec388d9e6"}, {"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000086560/"}], "identifiers": [{"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000086560"}, {"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD022934"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}], "instruments": [{"accession": "MS:1002732", "name": "Orbitrap Fusion Lumos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Glioblastoma"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "proteasome"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "PTEN"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "organoids"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "neurospheres"}], "modifications": [{"accession": "UNIMOD:35", "name": "Oxidation"}], "publications": [{"terms": [{"accession": "MS:1002853", "name": "Dataset with no associated published manuscript"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "human"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "PTEN DEFICIENCY LEADS TO PROTEASOME ADDICTION, A NOVEL VULNERABILITY IN GLIOBLASTOMA"}